Correlation Between ImmuCell and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both ImmuCell and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuCell and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmuCell and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on ImmuCell and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuCell with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuCell and Cadrenal Therapeutics,.
Diversification Opportunities for ImmuCell and Cadrenal Therapeutics,
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between ImmuCell and Cadrenal is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding ImmuCell and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and ImmuCell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuCell are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of ImmuCell i.e., ImmuCell and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between ImmuCell and Cadrenal Therapeutics,
Given the investment horizon of 90 days ImmuCell is expected to generate 0.25 times more return on investment than Cadrenal Therapeutics,. However, ImmuCell is 3.93 times less risky than Cadrenal Therapeutics,. It trades about 0.11 of its potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about -0.03 per unit of risk. If you would invest 357.00 in ImmuCell on August 29, 2024 and sell it today you would earn a total of 13.00 from holding ImmuCell or generate 3.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ImmuCell vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| ImmuCell |
| Cadrenal Therapeutics, |
ImmuCell and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ImmuCell and Cadrenal Therapeutics,
The main advantage of trading using opposite ImmuCell and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuCell position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| ImmuCell vs. Transgene SA | ImmuCell vs. Alpha Cognition | ImmuCell vs. Fennec Pharmaceuticals | ImmuCell vs. Lipella Pharmaceuticals Common |
| Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. Scpharmaceuticals | Cadrenal Therapeutics, vs. Milestone Pharmaceuticals | Cadrenal Therapeutics, vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |